| Heading: |
Diethylstilbestrol |
| Question ID: |
1784943 |
| UIN: |
38407 |
| House: |
Commons |
| Date tabled: |
2025-03-14 |
| Asking Member ID: |
5070 |
| Asking Member display name: |
Lisa Smart
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Lisa Smart
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if his Department will take steps to support people who have reported (a) long-term health and (b) personal impacts due to being prescribed Diethylstilbestrol (DES) between 1950 and 1980. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-26 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines supplied in the United Kingdom. Our activity spans the whole of a medicine’s lifecycle. Diethylstilboestrol (DES) is an oestrogenic hormone formerly used in the treatment o... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |